公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 GRIFOLS BRASIL LTDA取消

48 记录

产品持有公司班级有效性
Discriminatory Probe Reagent kit (Procleix UltrioPlex E)80134860320GRIFOLS BRASIL LTDAIV15/09/2035
Essential II Control80134860214GRIFOLS BRASIL LTDAIV03/11/2035
Extended IV Control80134860213GRIFOLS BRASIL LTDAIV03/11/2035
Família Anti-Kpa Dual e Anti-Kpb Dual80134860261GRIFOLS BRASIL LTDAIV03/06/2029
Família Procleix UltrioPlex E Assay Calibrators80134860314GRIFOLS BRASIL LTDAIV23/06/2035
Família Reverse-Cyte® 5%80134860273GRIFOLS BRASIL LTDAIV28/12/2030
ID CORE CONTROL80134860315GRIFOLS BRASIL LTDAIV30/06/2035
ID CORE XT Reagents80134860219GRIFOLS BRASIL LTDAIV04/07/2036
ID RHD XT REAGENTES80134860307GRIFOLS BRASIL LTDAIV18/03/2034
PROCLEIX ULTRIO ELITE Assay80134860220GRIFOLS BRASIL LTDAIV04/07/2036
Procleix ArboPlex Assay80134860311GRIFOLS BRASIL LTDAIV07/04/2035
Procleix ArboPlex Assay Calibrators80134860312GRIFOLS BRASIL LTDAIV07/04/2035
Procleix Plasmodium Assay80134860289GRIFOLS BRASIL LTDAIV05/06/2033
Procleix Plasmodium Assay Calibrators80134860322GRIFOLS BRASIL LTDAIV16/03/2036
Procleix Ultrio Elite Assay Calibrators80134860317GRIFOLS BRASIL LTDAIV07/07/2035
Procleix UltrioPlex E Assay80134860306GRIFOLS BRASIL LTDAIV19/02/2034
Procleix Zika Vírus80134860266GRIFOLS BRASIL LTDAIV30/09/2029
Reverse-Cyte 0.8%80134860269GRIFOLS BRASIL LTDAIV25/11/2029
SERIGRUP DIANA 480134860102GRIFOLS BRASIL LTDAIV09/04/2027
SERIGRUP DIANA A1/B80134860084GRIFOLS BRASIL LTDAIV28/12/2034
SERIGRUP DIANA A280134860105GRIFOLS BRASIL LTDAIV23/04/2027
Target Enhancer Reagent Kit - Procleix Ultrio Elite Assay80134860319GRIFOLS BRASIL LTDAIV28/07/2035
Weak D Control80134860329GRIFOLS BRASIL LTDAIV16/11/2036

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家